Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.
Hubner, Richard A Riley, R D Billingham, L J Popat, S
Hubner, Richard A
Riley, R D
Billingham, L J
Popat, S
Citations
Altmetric:
Abstract
Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis.
Description
Date
2011
Publisher
Collections
Keywords
Type
Article
Citation
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations. 2011, 6 (10):e25164 PLoS ONE